MiR-221-3p suppresses angiogenesis in endothelial cells by targeting HIF-1α, with evidence showing that blocking miR-221-3p enhances cardiac function in mice with transverse aortic constriction (TAC)-induced heart failure (17). This evidence concerns the gene HIF1A and persistent truncus arteriosus.